Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
V.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.149SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.413SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.258.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
B.1.9.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.107SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.4.10 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
B.47SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.36.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.41 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.71SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AS.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.142SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.166SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.4.11 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
B.1.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.34.2 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
B.1.1.50SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.60SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.52SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
W.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.250SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.63SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.27SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.23SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.130SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.44SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.469SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.311SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.93SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.104SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.258.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.225SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
A.2.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AV.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.309SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.105SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
B.1.177.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.258.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.1.307SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.171SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.57SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.67SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used